|
DNMT3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.201600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.110500E-02 |
| Normal-vs-Stage2 |
7.743000E-01 |
| Normal-vs-Stage3 |
9.314200E-01 |
| Normal-vs-Stage4 |
7.465800E-01 |
| Stage1-vs-Stage2 |
1.077620E-01 |
| Stage1-vs-Stage3 |
5.919600E-02 |
| Stage1-vs-Stage4 |
9.312400E-02 |
| Stage2-vs-Stage3 |
8.178200E-01 |
| Stage2-vs-Stage4 |
9.869600E-01 |
| Stage3-vs-Stage4 |
8.160800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.369630E-01 |
| Normal-vs-AfricanAmerican |
8.544600E-01 |
| Normal-vs-Asian |
2.574200E-01 |
| Caucasian-vs-AfricanAmerican |
5.363000E-01 |
| Caucasian-vs-Asian |
9.998800E-01 |
| AfricanAmerican-vs-Asian |
5.242000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.767030E-01 |
| Normal-vs-Female |
4.830000E-01 |
| Male-vs-Female |
3.193200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.040000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.739200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.513000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.135000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.360620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.917600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.454000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.905200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.067800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.424800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.104300E-02 |
| Classical-VS-Follicular |
5.95270000000037E-05 |
| Classical-VS-Other |
3.915800E-01 |
| Classical-VS-Normal |
1.388220E-02 |
| Tall-VS-Follicular |
5.405800E-01 |
| Tall-VS-Other |
7.315400E-01 |
| Tall-VS-Normal |
4.420400E-01 |
| Follicular-VS-Other |
5.402200E-01 |
| Follicular-VS-Normal |
8.016300E-02 |
| Other-VS-Normal |
9.472200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.290600E-01 |
| Normal-vs-N1 |
8.030600E-01 |
| N0-vs-N1 |
9.833800E-01 |
|
|
